In August 2016, the U.S. Federal Trade Commission (FTC) filed a suit against OMICS, two of its affiliated companies and Gedela, charging them with deceptive publishing practices[23] and seeking an unspecified monetary reimbursement for academics, duped by them.[2] In its first-ever suit against an academic publisher,[35] they alleged OMICS' peer-review processes to be a "sham" and their claiming of renowned academics in their editorial board and/or as speakers at its conferences without their consent to be intentionally deceptive.[1] The FTC also noted a failure to disclose publishing fees prior to accepting pieces, citing of dubious impact factors and false assertions about their journals being indexed in PubMed, when they are not.[1]